Let’s explore Stanley Druckenmiller’s portfolio, which has seen much change since our last update. Still, his preferred sectors are tech and health, which we can see from his current holdings.
When looking for investment inspiration, it's a great idea to consider what some of the world's most successful investors are ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
It's no secret that Stanley Druckenmiller has a unique ... CPNG is still in the No. 2 spot but with a 9.7% share of the portfolio, after Druckenmiller's 724,952-share addition.
Stanley Druckenmiller, whose net worth is around ... Below are those key holdings and how much of the portfolio each makes up: Source: Duquesne Family Office 13F filing for Q4 2024.
10d
24/7 Wall St. on MSNDid Billionaire Stan Druckenmiller Sell Nvidia Too Early, Or Just The Right Time?Stanley Druckenmiller is a legendary billionaire investor and former hedge fund manager who has generated a significant following due to his sharp market insights and strategic investment decisions.
Druckenmiller increased stake in United States Steel as company explores merger options. Company's stock up 25% due to Trump's tariffs.
Once every quarter, we -- and I mean investors of every portfolio size ... One particular billionaire to watch is Stanley Druckenmiller, the investor who led Duquesne Capital Management to ...
The most significant addition was United Airlines Holdings Inc (NASDAQ:UAL), with 1,043,805 shares, accounting for 2.72% of the portfolio and a total value of $101,350,000. The second largest addition ...
Billionaire Stanley Druckenmiller has a long track record ... With its dominance in the AI chip market, full portfolio of AI products and services, and focus on innovation, Nvidia is well ...
Stanley Druckenmiller and his Duquesne Family Office ... making it around 2% of the total portfolio value. I think this is a great move because Amazon has a ton going for it right now.
Closely followed investor Stanley Druckenmiller increased exposure ... with a stake representing just over 15% of its portfolio in the clinical genetic-testing company it has owned since 2022 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results